Pancreatitis

Pancreatitis is inflammation of the pancreas. It appears as a warning on every GLP-1 label, and it’s the kind of term that produces late-night anxiety searches — so here’s the calm, accurate version.

How worried to be

Pancreatitis is a rare side effect. Large trials and reviews have not shown a clearly increased rate on GLP-1 medications compared with placebo, and the absolute numbers are low. It remains a labeled warning because it’s serious when it does happen, not because it’s common. Both facts are true: unlikely, but worth knowing the signs.

The symptom that matters

You don’t need to memorize the biology — you need to recognize one pattern:

Severe, persistent abdominal pain — often in the upper belly, sometimes radiating to the back — that may come with nausea and vomiting and doesn’t ease up.

This is different from ordinary GLP-1 queasiness or the ache of an overfull stomach. It’s severe, it persists, and it often bores through to the back. That combination means stop taking the medication and seek medical care promptly — not wait for your next appointment.

Who’s at higher risk

A history of pancreatitis, gallstones, or heavy alcohol use raises baseline risk — all worth telling your prescriber before starting. Rapid weight loss itself also raises gallstone risk, and gallstones are themselves a pancreatitis trigger, so the concerns cluster.

The point isn’t fear — it’s pattern recognition. Almost all GLP-1 abdominal discomfort is benign and dose-related. This specific, severe, persistent presentation is the exception that earns a same-day call.